Endothelin Receptor A Blockade Enhances Taxane Effects in Prostate Cancer
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Endothelin-1 promotes cell survival in renal cell carcinoma through the ETA receptorCancer Letters, 2007
- Mechanosensation and endothelin in astrocytes—hypothetical roles in CNS pathophysiologyBrain Research Reviews, 2005
- The Evolving Role of Docetaxel in the Management of Androgen Independent Prostate CancerJournal of Urology, 2003
- Suppression of Prostate Cancer Induced Bone Remodeling by The Endothelin Receptor a Antagonist AtrasentanJournal of Urology, 2003
- Atrasentan, an Endothelin-Receptor Antagonist for Refractory Adenocarcinomas: Safety and PharmacokineticsJournal of Clinical Oncology, 2002
- EXPRESSION OF ENDOTHELIN RECEPTOR A ASSOCIATED WITH PROSTATE CANCER PROGRESSIONJournal of Urology, 2001
- Modulation of Human Colon Tumor-Stromal Interactions by the Endothelin SystemThe American Journal of Pathology, 2000
- Role of Endothelin-1 in Neovascularization of Ovarian CarcinomaThe American Journal of Pathology, 2000
- Expression of endothelin 1 and endothelin A receptor in HPV‐associated cervical carcinoma: new potential targets for anticancer therapyThe FASEB Journal, 2000
- Pharmacokinetics and pharmacodynamic effects of ABT‐627, an oral ETA selective endothelin antagonist, in humansBritish Journal of Clinical Pharmacology, 2000